Tag Archives: over

Kagool’s latest research finds that senior IT leaders have major concerns over their SAP S/4 data migration journey

Kagool’s latest research finds that senior IT leaders have concerns over their SAP S/4 data migration. The main concerns are data quality, data strategy, complexity of data landscape and data governance. Data migrations are often fraught with issues, complications and delays, causing projects to run massively overbudget. According to Gartner, 83% of data migrations fail… Read More »

Variety & Enjoyment: At the BIOFACH joint booth of the Italian Trade Agency, 62 businesses from all over Italy present the culinary delicacies they have to offer

Italy is leading the field when it comes to organically grown produce.Italy counts among the leading producers of organic products worldwide. Domestic sales as well as exports have increased steadily in recent years. With an export volume estimated at 3.37 billion euros in 2022 (+ 16% in comparison with 2021), Italy currently holds first place… Read More »

Over 100,000 Released Documents Expose COVID Origin Fraud

In a March 31, 2022, investigative report,1 Vanity Fair contributor Katherine Eban reviewed the contents of more than 100,000 EcoHealth Alliance documents, including meeting minutes and internal emails and reports, most of which predate the COVID-19 pandemic, showing a disturbing reality of “murky grant agreements, flimsy NIH oversight and pursuit of government grants by pitching… Read More »

Supreme Court will hear case over Trump admin’s 340B drug program cuts to hospitals

Dive Brief: The Supreme Court has agreed to hear a case involving the Trump administration’s cuts of Medicare Part B reimbursement for drugs that hospitals obtain under the 340B program. The case pivots on whether CMS has the authority to make payment cuts under the outpatient prospective payment system. The justices are expected to hear… Read More »

Astellas’ Xtandi nabs leg up over Johnson & Johnson’s Erleada with NICE prostate cancer win in UK

During the pandemic, Astellas’ oral prostate cancer drug Xtandi scored an interim nod in England as a “COVID friendly” way to treat men at home instead of in hospitals. With the pandemic easing there, cost watchdogs are backing the drug’s use for thousands of patients, offering the company an edge over its rival Johnson & Johnson. The National… Read More »